Peabody Energy $250 million convertible senior notes offering
We advised the initial purchasers on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Editas Medicine $125 million follow-on offering
We advised the joint book-running managers on the offering
newcleo combination with NewHold Investment Corp III and PIPE financing
We are advising newcleo on the transaction with the SPAC
Sabre $150 million private placement of exchangeable notes
We advised Sabre on the private placement
GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program
Tempus AI $460 million convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
CellCentric $220 million Series D financing round
We advised Venrock Healthcare Capital Partners
GH Research $117.5 million follow-on offering
We advised GH Research on the offering
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
Vistra $4 billion senior notes offering
We advised the representatives of the several underwriters on the offering